Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal Creteil
About this trial
This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
Eligibility criteria
Qualifiers
Male or female ≥ 18 years
Histologically proven invasive or microinvasive squamous cell carcinoma of the anus
Affiliated with a social security system
Disqualifiers
Refusal to participate in the protocol
Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc.
Time since treatment initiation greater than 6 months
Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).
Trial design
Treatments tested in this trial
- self-administered questionnaire
Treatment groups
300 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov